Basic Information
Avitia Delivers Advanced NGS Molecular Testing Solutions Directly to Labs Through Its AI/ML Platform. The Company’s Modular Precision Medicine Technology Offers Cutting-Edge NGS Capabilities and Network-Wide Insights for Cancer Centers. With Avitia’s Automated Platform, Any Lab Can Perform Liquid Biopsy Testing On-Site, Reducing Turnaround Time and Costs While Improving Patient Outcomes. Avitia’s Solutions Are Available Wherever Doctors Treat Patients, Allowing Local Oncologists to Best Serve Their Communities.